Literature DB >> 21049583

Insights into GPCR pharmacology from the measurement of changes in intracellular cyclic AMP; advantages and pitfalls of differing methodologies.

Stephen J Hill1, Christine Williams, Lauren T May.   

Abstract

It is clear that the G protein-coupled receptor family play a key role in the pharmaceutical industry, with a significant proportion of approved drugs targeting this protein class. While our growing understanding of the complexity of G protein-coupled receptor pharmacology is playing a key role in the future success of these endeavours, with allosteric mechanisms now well integrated into the industrial community and G protein-independent signalling mechanisms establishing themselves as novel phenomenon to be exploited, it is still possible to underestimate the complexity of G protein signal transduction mechanisms and the impact that inappropriate study of these mechanisms can have on data interpretation. In this manuscript we review different approaches to measuring the cAMP signal transduction pathway, with particular emphasis on key parameters influencing the data quality and biological relevance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21049583      PMCID: PMC3000652          DOI: 10.1111/j.1476-5381.2010.00779.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  58 in total

1.  Influence of rolipram on the cyclic 3',5'-adenosine monophosphate response to histamine and adenosine in slices of guinea-pig cerebral cortex.

Authors:  J Donaldson; A M Brown; S J Hill
Journal:  Biochem Pharmacol       Date:  1988-02-15       Impact factor: 5.858

2.  The A, B, Cs of G-protein-coupled receptor pharmacology in assay development for HTS.

Authors:  Dj McLoughlin; F Bertelli; C Williams
Journal:  Expert Opin Drug Discov       Date:  2007-05       Impact factor: 6.098

3.  Regulation of adenosine cyclic 3',5'-phosphate formation in cerebral cortical slices. Interaction among norepinephrine, histamine, serotonin.

Authors:  M Huang; H Shimizu; J Daly
Journal:  Mol Pharmacol       Date:  1971-03       Impact factor: 4.436

Review 4.  Molecular biological approaches to unravel adenylyl cyclase signaling and function.

Authors:  T B Patel; Z Du; S Pierre; L Cartin; K Scholich
Journal:  Gene       Date:  2001-05-16       Impact factor: 3.688

5.  Crystal structures of the catalytic domain of phosphodiesterase 4B complexed with AMP, 8-Br-AMP, and rolipram.

Authors:  Robert X Xu; Warren J Rocque; Millard H Lambert; Dana E Vanderwall; Michael A Luther; Robert T Nolte
Journal:  J Mol Biol       Date:  2004-03-19       Impact factor: 5.469

6.  Influence of receptor number on the stimulation by salmeterol of gene transcription in CHO-K1 cells transfected with the human beta2-adrenoceptor.

Authors:  J McDonnell; M L Latif; E S Rees; N J Bevan; S J Hill
Journal:  Br J Pharmacol       Date:  1998-10       Impact factor: 8.739

7.  High throughput screening technologies for direct cyclic AMP measurement.

Authors:  Daniela Gabriel; Magali Vernier; Martin J Pfeifer; Boris Dasen; Laurent Tenaillon; Rochdi Bouhelal
Journal:  Assay Drug Dev Technol       Date:  2003-04       Impact factor: 1.738

8.  A genetically encoded, fluorescent indicator for cyclic AMP in living cells.

Authors:  M Zaccolo; F De Giorgi; C Y Cho; L Feng; T Knapp; P A Negulescu; S S Taylor; R Y Tsien; T Pozzan
Journal:  Nat Cell Biol       Date:  2000-01       Impact factor: 28.824

9.  Fluorescence resonance energy transfer-based analysis of cAMP dynamics in live neonatal rat cardiac myocytes reveals distinct functions of compartmentalized phosphodiesterases.

Authors:  Marco Mongillo; Theresa McSorley; Sandrine Evellin; Arvind Sood; Valentina Lissandron; Anna Terrin; Elaine Huston; Annette Hannawacker; Martin J Lohse; Tullio Pozzan; Miles D Houslay; Manuela Zaccolo
Journal:  Circ Res       Date:  2004-06-03       Impact factor: 17.367

10.  A comparison of donor-acceptor pairs for genetically encoded FRET sensors: application to the Epac cAMP sensor as an example.

Authors:  Gerard N M van der Krogt; Janneke Ogink; Bas Ponsioen; Kees Jalink
Journal:  PLoS One       Date:  2008-04-02       Impact factor: 3.240

View more
  14 in total

1.  BJP issue on drug discovery.

Authors:  Steven J Charlton; Richard A Bond
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

2.  Ligand-selective activation of heterologously-expressed mammalian olfactory receptor.

Authors:  K Ukhanov; Y Bobkov; E A Corey; B W Ache
Journal:  Cell Calcium       Date:  2014-08-04       Impact factor: 6.817

3.  Screening for positive allosteric modulators of cholecystokinin type 1 receptor potentially useful for management of obesity.

Authors:  Daniela G Dengler; Qing Sun; Kaleeckal G Harikumar; Laurence J Miller; Eduard A Sergienko
Journal:  SLAS Discov       Date:  2022-07-16       Impact factor: 3.341

4.  Agonists with supraphysiological efficacy at the muscarinic M2 ACh receptor.

Authors:  R Schrage; W K Seemann; J Klöckner; C Dallanoce; K Racké; E Kostenis; M De Amici; U Holzgrabe; K Mohr
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

5.  Assessment of biased agonism at the A3 adenosine receptor using β-arrestin and miniGαi recruitment assays.

Authors:  Eline Pottie; Dilip K Tosh; Zhan-Guo Gao; Kenneth A Jacobson; Christophe P Stove
Journal:  Biochem Pharmacol       Date:  2020-03-26       Impact factor: 5.858

Review 6.  Novel cAMP signalling paradigms: therapeutic implications for airway disease.

Authors:  Charlotte K Billington; Ian P Hall
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

7.  Differential In Vitro Pharmacological Profiles of Structurally Diverse Nociceptin Receptor Agonists in Activating G Protein and Beta-Arrestin Signaling at the Human Nociceptin Opioid Receptor.

Authors:  James J Lu; Willma E Polgar; Anika Mann; Pooja Dasgupta; Stefan Schulz; Nurulain T Zaveri
Journal:  Mol Pharmacol       Date:  2021-05-06       Impact factor: 4.054

8.  PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome.

Authors:  Wesley K Kroeze; Maria F Sassano; Xi-Ping Huang; Katherine Lansu; John D McCorvy; Patrick M Giguère; Noah Sciaky; Bryan L Roth
Journal:  Nat Struct Mol Biol       Date:  2015-04-20       Impact factor: 15.369

Review 9.  Genetically-encoded tools for cAMP probing and modulation in living systems.

Authors:  Valeriy M Paramonov; Veronika Mamaeva; Cecilia Sahlgren; Adolfo Rivero-Müller
Journal:  Front Pharmacol       Date:  2015-09-15       Impact factor: 5.810

10.  Gpbar1 agonism promotes a Pgc-1α-dependent browning of white adipose tissue and energy expenditure and reverses diet-induced steatohepatitis in mice.

Authors:  Adriana Carino; Sabrina Cipriani; Silvia Marchianò; Michele Biagioli; Paolo Scarpelli; Angela Zampella; Maria Chiara Monti; Stefano Fiorucci
Journal:  Sci Rep       Date:  2017-10-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.